Morepen transfers subsidiary shares to key management
Published on: May 20, 2026, 10:30 p.m. | Source: scanx.trade
Morepen Laboratories Limited transferred 1,62,000 equity shares of subsidiary Morepen Medipath Limited to Mr. Anubhav Suri, Head - Medical Devices Business. This reduces the company's stake in MML to 51%, though it remains a subsidiary. Mr. Suri's shareholding increased from 0.10% to 9.10%.
